TrialBMC cancer2015

Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer.

Yoshinori Munemoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.